Population
Patients receiving chemotherapy (specifically anthracyclines) at risk for cardiovascular dysfunction
Design
Review
Authors
Loading...
Anthracycline cardiotoxicity via oxidative stress warrants monitoring in cancer patients; leaves open mtDNA-targeted cardioprotection strategies.
Telomerase activity and novel biomarkers offer promising avenues for the early detection and mitigation of chemotherapy-induced cardiovascular damage.
Quryshi et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: